http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11746110-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4cd9a2ae528abb61034e08fa7c2d918 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2023-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae8ffcd264e309d8c44eee6022d67a71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b28f80aa41f1976c438bd35486ae0981 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da3044eac224813411b3ef868c3e1c9f |
publicationDate | 2023-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-11746110-B2 |
titleOfInvention | Alkynyl (hetero) aromatic ring compounds used for inhibiting protein kinase activity |
abstract | Disclosed are alkynyl (hetero) aromatic ring compounds that inhibit protein tyrosine kinases, pharmaceutical compositions comprising same, preparations therefor and uses thereof. Specifically, disclosed are an alkynyl (hetero) aromatic ring compound represented by formula (I), and a pharmaceutically acceptable salt, a stereoisomer, a solvate, a hydrate, a crystal form, a prodrug or an isotope variant thereof. The disclosed compounds may be used in the treatment and/or prevention of diseases associated with protein tyrosine kinase, such as in preventing tumors. |
priorityDate | 2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.